By targeting the underlying drivers of disease with a pipeline of complementary candidates, Kardigan is building a platform that accelerates insights into core cardiovascular pathways to address multiple conditions where no treatments exist SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.–(BUSINESS WIRE)–Kardigan, a heart health company modernizing cardiovascular drug development, today […]